Stay updated on Long-term Safety of SAGE-324 in Essential Tremor Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of SAGE-324 in Essential Tremor Clinical Trial page.

Latest updates to the Long-term Safety of SAGE-324 in Essential Tremor Clinical Trial page
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated to v3.5.0 from v3.4.3.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.0%

- Check69 days agoChange DetectedThe study documents were updated to Revision: v3.4.2, replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page shows a minor revision from v3.4.0 to v3.4.1; there are no changes to the study data or main content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check98 days agoChange DetectedThe page displays a revision update from v3.3.3 to v3.3.4. This appears to be a minor version update without changes to core study details.SummaryDifference0.0%

- Check127 days agoChange DetectedAdded a Locations section listing study sites by state (Alabama, Arizona, California, Colorado, Florida, Georgia, Kansas, Kentucky, Louisiana, Massachusetts, Michigan, New York, North Carolina, Ohio, Oklahoma, Tennessee, Texas, Virginia, Washington) and updated the revision label to v3.3.3. The HHS Vulnerability Disclosure link and prior location listings were removed.SummaryDifference2%

Stay in the know with updates to Long-term Safety of SAGE-324 in Essential Tremor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of SAGE-324 in Essential Tremor Clinical Trial page.